nodes	percent_of_prediction	percent_of_DWPC	metapath
Flupentixol—ABCB1—peripheral nervous system neoplasm	0.605	1	CbGaD
Flupentixol—ABCB1—Topotecan—peripheral nervous system neoplasm	0.0575	0.239	CbGbCtD
Flupentixol—ABCB1—Alitretinoin—peripheral nervous system neoplasm	0.0575	0.239	CbGbCtD
Flupentixol—ABCB1—Dactinomycin—peripheral nervous system neoplasm	0.0399	0.166	CbGbCtD
Flupentixol—ABCB1—Vincristine—peripheral nervous system neoplasm	0.0246	0.102	CbGbCtD
Flupentixol—ABCB1—Cisplatin—peripheral nervous system neoplasm	0.0229	0.0953	CbGbCtD
Flupentixol—ABCB1—Etoposide—peripheral nervous system neoplasm	0.0225	0.0937	CbGbCtD
Flupentixol—ABCB1—Doxorubicin—peripheral nervous system neoplasm	0.0153	0.0639	CbGbCtD
Flupentixol—HTR2A—phrenic nerve—peripheral nervous system neoplasm	0.0145	0.186	CbGeAlD
Flupentixol—DDC—nerve—peripheral nervous system neoplasm	0.00677	0.0868	CbGeAlD
Flupentixol—DDC—ganglion—peripheral nervous system neoplasm	0.00669	0.0857	CbGeAlD
Flupentixol—HTR2A—trigeminal nerve—peripheral nervous system neoplasm	0.00531	0.0681	CbGeAlD
Flupentixol—DRD1—nerve—peripheral nervous system neoplasm	0.00498	0.0638	CbGeAlD
Flupentixol—HTR2A—vagus nerve—peripheral nervous system neoplasm	0.00497	0.0637	CbGeAlD
Flupentixol—DRD1—ganglion—peripheral nervous system neoplasm	0.00491	0.063	CbGeAlD
Flupentixol—HTR2A—cranial nerve—peripheral nervous system neoplasm	0.00378	0.0485	CbGeAlD
Flupentixol—HTR2A—pons—peripheral nervous system neoplasm	0.00374	0.0479	CbGeAlD
Flupentixol—DRD2—nerve—peripheral nervous system neoplasm	0.00294	0.0377	CbGeAlD
Flupentixol—DDC—brainstem—peripheral nervous system neoplasm	0.00291	0.0373	CbGeAlD
Flupentixol—DRD2—ganglion—peripheral nervous system neoplasm	0.0029	0.0372	CbGeAlD
Flupentixol—DRD1—brainstem—peripheral nervous system neoplasm	0.00214	0.0274	CbGeAlD
Flupentixol—HTR2A—nerve—peripheral nervous system neoplasm	0.00194	0.0249	CbGeAlD
Flupentixol—HTR2A—ganglion—peripheral nervous system neoplasm	0.00192	0.0245	CbGeAlD
Flupentixol—CHRM1—parotid gland—peripheral nervous system neoplasm	0.00167	0.0214	CbGeAlD
Flupentixol—ADRA1A—brainstem—peripheral nervous system neoplasm	0.00129	0.0165	CbGeAlD
Flupentixol—DRD2—brainstem—peripheral nervous system neoplasm	0.00126	0.0162	CbGeAlD
Flupentixol—HTR2A—brainstem—peripheral nervous system neoplasm	0.000833	0.0107	CbGeAlD
Flupentixol—ADRA1A—cerebellum—peripheral nervous system neoplasm	0.000635	0.00814	CbGeAlD
Flupentixol—DRD2—cerebellum—peripheral nervous system neoplasm	0.000622	0.00797	CbGeAlD
Flupentixol—ABCB1—trigeminal ganglion—peripheral nervous system neoplasm	0.000616	0.0079	CbGeAlD
Flupentixol—HTR2A—cerebellum—peripheral nervous system neoplasm	0.00041	0.00526	CbGeAlD
Flupentixol—ABCB1—cerebellum—peripheral nervous system neoplasm	0.000269	0.00345	CbGeAlD
Flupentixol—HTR2A—SIDS Susceptibility Pathways—NTRK2—peripheral nervous system neoplasm	0.000252	0.00328	CbGpPWpGaD
Flupentixol—ABCB1—Integrated Pancreatic Cancer Pathway—NME1—peripheral nervous system neoplasm	0.000246	0.0032	CbGpPWpGaD
Flupentixol—DDC—SIDS Susceptibility Pathways—CASP3—peripheral nervous system neoplasm	0.000242	0.00315	CbGpPWpGaD
Flupentixol—HTR2A—SIDS Susceptibility Pathways—TH—peripheral nervous system neoplasm	0.000231	0.003	CbGpPWpGaD
Flupentixol—DRD1—Circadian rythm related genes—NTRK1—peripheral nervous system neoplasm	0.000225	0.00294	CbGpPWpGaD
Flupentixol—DRD2—GPCR ligand binding—NTS—peripheral nervous system neoplasm	0.000212	0.00277	CbGpPWpGaD
Flupentixol—HTR2A—GPCR ligand binding—NTS—peripheral nervous system neoplasm	0.000209	0.00272	CbGpPWpGaD
Flupentixol—CHRM1—GPCR ligand binding—NTS—peripheral nervous system neoplasm	0.000208	0.00271	CbGpPWpGaD
Flupentixol—ADRA1A—GPCR ligand binding—NTS—peripheral nervous system neoplasm	0.000205	0.00267	CbGpPWpGaD
Flupentixol—DRD2—GPCR ligand binding—CD55—peripheral nervous system neoplasm	0.000204	0.00265	CbGpPWpGaD
Flupentixol—HTR2A—GPCR ligand binding—CD55—peripheral nervous system neoplasm	0.0002	0.00261	CbGpPWpGaD
Flupentixol—CHRM1—GPCR ligand binding—CD55—peripheral nervous system neoplasm	0.000199	0.0026	CbGpPWpGaD
Flupentixol—ADRA1A—GPCR ligand binding—CD55—peripheral nervous system neoplasm	0.000196	0.00256	CbGpPWpGaD
Flupentixol—DDC—Metabolism—GNS—peripheral nervous system neoplasm	0.000195	0.00255	CbGpPWpGaD
Flupentixol—CHRM1—Calcium Regulation in the Cardiac Cell—GNAS—peripheral nervous system neoplasm	0.000194	0.00253	CbGpPWpGaD
Flupentixol—DRD2—Circadian rythm related genes—TH—peripheral nervous system neoplasm	0.000191	0.00249	CbGpPWpGaD
Flupentixol—ADRA1A—Calcium Regulation in the Cardiac Cell—GNAS—peripheral nervous system neoplasm	0.000191	0.00249	CbGpPWpGaD
Flupentixol—HTR2A—SIDS Susceptibility Pathways—BDNF—peripheral nervous system neoplasm	0.000188	0.00245	CbGpPWpGaD
Flupentixol—DDC—Metabolism—NME1—peripheral nervous system neoplasm	0.000187	0.00244	CbGpPWpGaD
Flupentixol—CHRM1—Circadian rythm related genes—TH—peripheral nervous system neoplasm	0.000187	0.00244	CbGpPWpGaD
Flupentixol—HTR2A—G alpha (q) signalling events—KNG1—peripheral nervous system neoplasm	0.000186	0.00243	CbGpPWpGaD
Flupentixol—CHRM1—G alpha (q) signalling events—KNG1—peripheral nervous system neoplasm	0.000185	0.00241	CbGpPWpGaD
Flupentixol—ADRA1A—G alpha (q) signalling events—KNG1—peripheral nervous system neoplasm	0.000182	0.00238	CbGpPWpGaD
Flupentixol—DDC—Metabolism—COX2—peripheral nervous system neoplasm	0.00018	0.00235	CbGpPWpGaD
Flupentixol—DRD2—Circadian rythm related genes—NTRK1—peripheral nervous system neoplasm	0.00017	0.00222	CbGpPWpGaD
Flupentixol—CHRM1—Circadian rythm related genes—NTRK1—peripheral nervous system neoplasm	0.000167	0.00217	CbGpPWpGaD
Flupentixol—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—KNG1—peripheral nervous system neoplasm	0.000167	0.00217	CbGpPWpGaD
Flupentixol—DRD1—Class A/1 (Rhodopsin-like receptors)—KNG1—peripheral nervous system neoplasm	0.000166	0.00216	CbGpPWpGaD
Flupentixol—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—KNG1—peripheral nervous system neoplasm	0.000166	0.00216	CbGpPWpGaD
Flupentixol—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—KNG1—peripheral nervous system neoplasm	0.000163	0.00212	CbGpPWpGaD
Flupentixol—DRD1—GPCR downstream signaling—NTS—peripheral nervous system neoplasm	0.000159	0.00207	CbGpPWpGaD
Flupentixol—DRD2—G alpha (i) signalling events—KNG1—peripheral nervous system neoplasm	0.000158	0.00205	CbGpPWpGaD
Flupentixol—DRD1—Signaling by GPCR—NTS—peripheral nervous system neoplasm	0.000144	0.00188	CbGpPWpGaD
Flupentixol—DRD1—Signaling by GPCR—CD55—peripheral nervous system neoplasm	0.000138	0.0018	CbGpPWpGaD
Flupentixol—DRD2—G alpha (i) signalling events—GNAS—peripheral nervous system neoplasm	0.000138	0.0018	CbGpPWpGaD
Flupentixol—DDC—Circadian rythm related genes—TP53—peripheral nervous system neoplasm	0.000127	0.00165	CbGpPWpGaD
Flupentixol—DRD1—GPCR ligand binding—KNG1—peripheral nervous system neoplasm	0.000126	0.00165	CbGpPWpGaD
Flupentixol—DRD2—Class A/1 (Rhodopsin-like receptors)—KNG1—peripheral nervous system neoplasm	0.000125	0.00163	CbGpPWpGaD
Flupentixol—HTR2A—Class A/1 (Rhodopsin-like receptors)—KNG1—peripheral nervous system neoplasm	0.000123	0.00161	CbGpPWpGaD
Flupentixol—CHRM1—Class A/1 (Rhodopsin-like receptors)—KNG1—peripheral nervous system neoplasm	0.000123	0.0016	CbGpPWpGaD
Flupentixol—ADRA1A—Class A/1 (Rhodopsin-like receptors)—KNG1—peripheral nervous system neoplasm	0.000121	0.00157	CbGpPWpGaD
Flupentixol—DRD1—GPCR downstream signaling—VIP—peripheral nervous system neoplasm	0.00012	0.00157	CbGpPWpGaD
Flupentixol—ABCB1—Integrated Pancreatic Cancer Pathway—CHEK2—peripheral nervous system neoplasm	0.00012	0.00157	CbGpPWpGaD
Flupentixol—DRD2—GPCR downstream signaling—NTS—peripheral nervous system neoplasm	0.00012	0.00156	CbGpPWpGaD
Flupentixol—DDC—Metabolism—ENO2—peripheral nervous system neoplasm	0.000118	0.00154	CbGpPWpGaD
Flupentixol—HTR2A—GPCR downstream signaling—NTS—peripheral nervous system neoplasm	0.000118	0.00154	CbGpPWpGaD
Flupentixol—CHRM1—GPCR downstream signaling—NTS—peripheral nervous system neoplasm	0.000117	0.00153	CbGpPWpGaD
Flupentixol—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—peripheral nervous system neoplasm	0.000116	0.00152	CbGpPWpGaD
Flupentixol—ADRA1A—GPCR downstream signaling—NTS—peripheral nervous system neoplasm	0.000116	0.00151	CbGpPWpGaD
Flupentixol—ADRA1A—AMPK Signaling—TP53—peripheral nervous system neoplasm	0.000113	0.00147	CbGpPWpGaD
Flupentixol—DRD1—GPCR ligand binding—GNAS—peripheral nervous system neoplasm	0.000111	0.00144	CbGpPWpGaD
Flupentixol—ABCB1—Integrated Pancreatic Cancer Pathway—NTRK1—peripheral nervous system neoplasm	0.00011	0.00143	CbGpPWpGaD
Flupentixol—DRD1—Signaling by GPCR—VIP—peripheral nervous system neoplasm	0.000109	0.00143	CbGpPWpGaD
Flupentixol—DRD2—Signaling by GPCR—NTS—peripheral nervous system neoplasm	0.000109	0.00142	CbGpPWpGaD
Flupentixol—HTR2A—Signaling by GPCR—NTS—peripheral nervous system neoplasm	0.000107	0.0014	CbGpPWpGaD
Flupentixol—CHRM1—Signaling by GPCR—NTS—peripheral nervous system neoplasm	0.000107	0.00139	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling by GPCR—NTS—peripheral nervous system neoplasm	0.000105	0.00137	CbGpPWpGaD
Flupentixol—DRD2—Signaling by GPCR—CD55—peripheral nervous system neoplasm	0.000105	0.00136	CbGpPWpGaD
Flupentixol—HTR2A—Signaling by GPCR—CD55—peripheral nervous system neoplasm	0.000103	0.00134	CbGpPWpGaD
Flupentixol—CHRM1—Signaling by GPCR—CD55—peripheral nervous system neoplasm	0.000102	0.00133	CbGpPWpGaD
Flupentixol—ABCB1—Allograft Rejection—CASP3—peripheral nervous system neoplasm	0.000102	0.00133	CbGpPWpGaD
Flupentixol—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—PTPN11—peripheral nervous system neoplasm	0.000101	0.00132	CbGpPWpGaD
Flupentixol—DRD1—Signaling by GPCR—PPP3R1—peripheral nervous system neoplasm	0.000101	0.00132	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling by GPCR—CD55—peripheral nervous system neoplasm	0.000101	0.00131	CbGpPWpGaD
Flupentixol—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—PTPN11—peripheral nervous system neoplasm	0.000101	0.00131	CbGpPWpGaD
Flupentixol—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—peripheral nervous system neoplasm	0.0001	0.00131	CbGpPWpGaD
Flupentixol—DDC—Metabolism—BCHE—peripheral nervous system neoplasm	0.0001	0.0013	CbGpPWpGaD
Flupentixol—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—PTPN11—peripheral nervous system neoplasm	9.91e-05	0.00129	CbGpPWpGaD
Flupentixol—ABCB1—Metabolism—PPIP5K2—peripheral nervous system neoplasm	9.76e-05	0.00127	CbGpPWpGaD
Flupentixol—ADRA1A—AMPK Signaling—AKT1—peripheral nervous system neoplasm	9.55e-05	0.00124	CbGpPWpGaD
Flupentixol—DRD2—GPCR ligand binding—KNG1—peripheral nervous system neoplasm	9.54e-05	0.00124	CbGpPWpGaD
Flupentixol—DDC—Metabolism—SLC2A1—peripheral nervous system neoplasm	9.54e-05	0.00124	CbGpPWpGaD
Flupentixol—DDC—Metabolism—TH—peripheral nervous system neoplasm	9.4e-05	0.00123	CbGpPWpGaD
Flupentixol—ABCB1—Transmembrane transport of small molecules—COX2—peripheral nervous system neoplasm	9.39e-05	0.00122	CbGpPWpGaD
Flupentixol—HTR2A—GPCR ligand binding—KNG1—peripheral nervous system neoplasm	9.39e-05	0.00122	CbGpPWpGaD
Flupentixol—HTR2A—SIDS Susceptibility Pathways—CASP3—peripheral nervous system neoplasm	9.38e-05	0.00122	CbGpPWpGaD
Flupentixol—CHRM1—GPCR ligand binding—KNG1—peripheral nervous system neoplasm	9.34e-05	0.00122	CbGpPWpGaD
Flupentixol—ADRA1A—GPCR ligand binding—KNG1—peripheral nervous system neoplasm	9.2e-05	0.0012	CbGpPWpGaD
Flupentixol—DRD2—GPCR downstream signaling—VIP—peripheral nervous system neoplasm	9.1e-05	0.00119	CbGpPWpGaD
Flupentixol—HTR2A—GPCR downstream signaling—VIP—peripheral nervous system neoplasm	8.95e-05	0.00117	CbGpPWpGaD
Flupentixol—CHRM1—GPCR downstream signaling—VIP—peripheral nervous system neoplasm	8.9e-05	0.00116	CbGpPWpGaD
Flupentixol—ADRA1A—GPCR downstream signaling—VIP—peripheral nervous system neoplasm	8.76e-05	0.00114	CbGpPWpGaD
Flupentixol—DRD1—Signaling Pathways—NTS—peripheral nervous system neoplasm	8.53e-05	0.00111	CbGpPWpGaD
Flupentixol—DRD2—GPCR ligand binding—GNAS—peripheral nervous system neoplasm	8.35e-05	0.00109	CbGpPWpGaD
Flupentixol—DRD2—Signaling by GPCR—VIP—peripheral nervous system neoplasm	8.26e-05	0.00108	CbGpPWpGaD
Flupentixol—HTR2A—GPCR ligand binding—GNAS—peripheral nervous system neoplasm	8.21e-05	0.00107	CbGpPWpGaD
Flupentixol—DRD1—Signaling Pathways—CD55—peripheral nervous system neoplasm	8.18e-05	0.00107	CbGpPWpGaD
Flupentixol—CHRM1—GPCR ligand binding—GNAS—peripheral nervous system neoplasm	8.17e-05	0.00106	CbGpPWpGaD
Flupentixol—HTR2A—Signaling by GPCR—VIP—peripheral nervous system neoplasm	8.13e-05	0.00106	CbGpPWpGaD
Flupentixol—CHRM1—Regulation of Actin Cytoskeleton—NRAS—peripheral nervous system neoplasm	8.12e-05	0.00106	CbGpPWpGaD
Flupentixol—CHRM1—Signaling by GPCR—VIP—peripheral nervous system neoplasm	8.08e-05	0.00105	CbGpPWpGaD
Flupentixol—ADRA1A—GPCR ligand binding—GNAS—peripheral nervous system neoplasm	8.04e-05	0.00105	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling by GPCR—VIP—peripheral nervous system neoplasm	7.96e-05	0.00104	CbGpPWpGaD
Flupentixol—DDC—Metabolism—GNAS—peripheral nervous system neoplasm	7.68e-05	0.001	CbGpPWpGaD
Flupentixol—DRD2—Signaling by GPCR—PPP3R1—peripheral nervous system neoplasm	7.62e-05	0.000993	CbGpPWpGaD
Flupentixol—DDC—Metabolism—ABCB1—peripheral nervous system neoplasm	7.53e-05	0.000981	CbGpPWpGaD
Flupentixol—HTR2A—Signaling by GPCR—PPP3R1—peripheral nervous system neoplasm	7.5e-05	0.000977	CbGpPWpGaD
Flupentixol—CHRM1—Signaling by GPCR—PPP3R1—peripheral nervous system neoplasm	7.46e-05	0.000972	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling by GPCR—PPP3R1—peripheral nervous system neoplasm	7.34e-05	0.000957	CbGpPWpGaD
Flupentixol—DRD1—GPCR downstream signaling—KNG1—peripheral nervous system neoplasm	7.14e-05	0.000931	CbGpPWpGaD
Flupentixol—DRD1—Circadian rythm related genes—TP53—peripheral nervous system neoplasm	6.61e-05	0.000862	CbGpPWpGaD
Flupentixol—ABCB1—Metabolism—HSD17B12—peripheral nervous system neoplasm	6.59e-05	0.000859	CbGpPWpGaD
Flupentixol—DRD1—Signaling by GPCR—KNG1—peripheral nervous system neoplasm	6.49e-05	0.000845	CbGpPWpGaD
Flupentixol—DRD1—Signaling Pathways—VIP—peripheral nervous system neoplasm	6.46e-05	0.000842	CbGpPWpGaD
Flupentixol—DRD2—Signaling Pathways—NTS—peripheral nervous system neoplasm	6.44e-05	0.000839	CbGpPWpGaD
Flupentixol—ABCB1—HIF-1-alpha transcription factor network—AKT1—peripheral nervous system neoplasm	6.36e-05	0.000829	CbGpPWpGaD
Flupentixol—HTR2A—Signaling Pathways—NTS—peripheral nervous system neoplasm	6.34e-05	0.000825	CbGpPWpGaD
Flupentixol—CHRM1—Signaling Pathways—NTS—peripheral nervous system neoplasm	6.3e-05	0.000821	CbGpPWpGaD
Flupentixol—DRD1—GPCR downstream signaling—GNAS—peripheral nervous system neoplasm	6.25e-05	0.000814	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling Pathways—NTS—peripheral nervous system neoplasm	6.2e-05	0.000808	CbGpPWpGaD
Flupentixol—DRD2—Signaling Pathways—CD55—peripheral nervous system neoplasm	6.17e-05	0.000804	CbGpPWpGaD
Flupentixol—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—NRAS—peripheral nervous system neoplasm	6.09e-05	0.000793	CbGpPWpGaD
Flupentixol—HTR2A—Signaling Pathways—CD55—peripheral nervous system neoplasm	6.07e-05	0.000791	CbGpPWpGaD
Flupentixol—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—NRAS—peripheral nervous system neoplasm	6.05e-05	0.000789	CbGpPWpGaD
Flupentixol—CHRM1—Signaling Pathways—CD55—peripheral nervous system neoplasm	6.04e-05	0.000787	CbGpPWpGaD
Flupentixol—DRD1—Signaling Pathways—PPP3R1—peripheral nervous system neoplasm	5.96e-05	0.000777	CbGpPWpGaD
Flupentixol—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—NRAS—peripheral nervous system neoplasm	5.96e-05	0.000776	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling Pathways—CD55—peripheral nervous system neoplasm	5.95e-05	0.000775	CbGpPWpGaD
Flupentixol—DRD1—Signaling by GPCR—GNAS—peripheral nervous system neoplasm	5.67e-05	0.000739	CbGpPWpGaD
Flupentixol—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—peripheral nervous system neoplasm	5.53e-05	0.000721	CbGpPWpGaD
Flupentixol—DRD2—GPCR downstream signaling—KNG1—peripheral nervous system neoplasm	5.39e-05	0.000703	CbGpPWpGaD
Flupentixol—HTR2A—GPCR downstream signaling—KNG1—peripheral nervous system neoplasm	5.31e-05	0.000691	CbGpPWpGaD
Flupentixol—CHRM1—GPCR downstream signaling—KNG1—peripheral nervous system neoplasm	5.28e-05	0.000688	CbGpPWpGaD
Flupentixol—ADRA1A—GPCR downstream signaling—KNG1—peripheral nervous system neoplasm	5.2e-05	0.000677	CbGpPWpGaD
Flupentixol—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—peripheral nervous system neoplasm	5.02e-05	0.000654	CbGpPWpGaD
Flupentixol—DRD2—Circadian rythm related genes—TP53—peripheral nervous system neoplasm	4.99e-05	0.00065	CbGpPWpGaD
Flupentixol—ABCB1—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	4.97e-05	0.000648	CbGpPWpGaD
Flupentixol—DRD2—Signaling by GPCR—KNG1—peripheral nervous system neoplasm	4.9e-05	0.000638	CbGpPWpGaD
Flupentixol—CHRM1—Circadian rythm related genes—TP53—peripheral nervous system neoplasm	4.89e-05	0.000637	CbGpPWpGaD
Flupentixol—DRD2—Signaling Pathways—VIP—peripheral nervous system neoplasm	4.88e-05	0.000636	CbGpPWpGaD
Flupentixol—HTR2A—Signaling by GPCR—KNG1—peripheral nervous system neoplasm	4.82e-05	0.000628	CbGpPWpGaD
Flupentixol—HTR2A—Signaling Pathways—VIP—peripheral nervous system neoplasm	4.8e-05	0.000626	CbGpPWpGaD
Flupentixol—CHRM1—Signaling by GPCR—KNG1—peripheral nervous system neoplasm	4.79e-05	0.000625	CbGpPWpGaD
Flupentixol—CHRM1—Signaling Pathways—VIP—peripheral nervous system neoplasm	4.78e-05	0.000622	CbGpPWpGaD
Flupentixol—ABCB1—Metabolism—GNS—peripheral nervous system neoplasm	4.77e-05	0.000621	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling by GPCR—KNG1—peripheral nervous system neoplasm	4.72e-05	0.000615	CbGpPWpGaD
Flupentixol—DRD2—GPCR downstream signaling—GNAS—peripheral nervous system neoplasm	4.72e-05	0.000614	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling Pathways—VIP—peripheral nervous system neoplasm	4.7e-05	0.000613	CbGpPWpGaD
Flupentixol—HTR2A—GPCR downstream signaling—GNAS—peripheral nervous system neoplasm	4.64e-05	0.000605	CbGpPWpGaD
Flupentixol—CHRM1—GPCR downstream signaling—GNAS—peripheral nervous system neoplasm	4.62e-05	0.000601	CbGpPWpGaD
Flupentixol—ABCB1—Metabolism—NME1—peripheral nervous system neoplasm	4.57e-05	0.000595	CbGpPWpGaD
Flupentixol—ADRA1A—GPCR downstream signaling—GNAS—peripheral nervous system neoplasm	4.54e-05	0.000592	CbGpPWpGaD
Flupentixol—DRD2—Signaling Pathways—PPP3R1—peripheral nervous system neoplasm	4.5e-05	0.000587	CbGpPWpGaD
Flupentixol—DRD1—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	4.48e-05	0.000584	CbGpPWpGaD
Flupentixol—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—peripheral nervous system neoplasm	4.45e-05	0.00058	CbGpPWpGaD
Flupentixol—HTR2A—Signaling Pathways—PPP3R1—peripheral nervous system neoplasm	4.43e-05	0.000577	CbGpPWpGaD
Flupentixol—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—peripheral nervous system neoplasm	4.43e-05	0.000577	CbGpPWpGaD
Flupentixol—CHRM1—Signaling Pathways—PPP3R1—peripheral nervous system neoplasm	4.41e-05	0.000574	CbGpPWpGaD
Flupentixol—ABCB1—Metabolism—COX2—peripheral nervous system neoplasm	4.4e-05	0.000573	CbGpPWpGaD
Flupentixol—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—peripheral nervous system neoplasm	4.36e-05	0.000568	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling Pathways—PPP3R1—peripheral nervous system neoplasm	4.34e-05	0.000565	CbGpPWpGaD
Flupentixol—DRD2—Signaling by GPCR—GNAS—peripheral nervous system neoplasm	4.28e-05	0.000558	CbGpPWpGaD
Flupentixol—HTR2A—Signaling by GPCR—GNAS—peripheral nervous system neoplasm	4.21e-05	0.000549	CbGpPWpGaD
Flupentixol—CHRM1—Signaling by GPCR—GNAS—peripheral nervous system neoplasm	4.19e-05	0.000546	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling by GPCR—GNAS—peripheral nervous system neoplasm	4.13e-05	0.000538	CbGpPWpGaD
Flupentixol—ABCB1—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	4e-05	0.000521	CbGpPWpGaD
Flupentixol—DRD1—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	3.94e-05	0.000514	CbGpPWpGaD
Flupentixol—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—peripheral nervous system neoplasm	3.92e-05	0.000511	CbGpPWpGaD
Flupentixol—DRD1—Signaling Pathways—KNG1—peripheral nervous system neoplasm	3.83e-05	0.000499	CbGpPWpGaD
Flupentixol—DRD1—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	3.65e-05	0.000476	CbGpPWpGaD
Flupentixol—DRD2—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	3.38e-05	0.000441	CbGpPWpGaD
Flupentixol—DRD1—Signaling Pathways—GNAS—peripheral nervous system neoplasm	3.35e-05	0.000437	CbGpPWpGaD
Flupentixol—HTR2A—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	3.33e-05	0.000434	CbGpPWpGaD
Flupentixol—CHRM1—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	3.31e-05	0.000431	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	3.26e-05	0.000425	CbGpPWpGaD
Flupentixol—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—peripheral nervous system neoplasm	3.22e-05	0.000419	CbGpPWpGaD
Flupentixol—DRD2—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	2.98e-05	0.000388	CbGpPWpGaD
Flupentixol—HTR2A—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	2.93e-05	0.000382	CbGpPWpGaD
Flupentixol—CHRM1—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	2.91e-05	0.00038	CbGpPWpGaD
Flupentixol—DRD2—Signaling Pathways—KNG1—peripheral nervous system neoplasm	2.89e-05	0.000377	CbGpPWpGaD
Flupentixol—ABCB1—Metabolism—ENO2—peripheral nervous system neoplasm	2.89e-05	0.000376	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	2.87e-05	0.000374	CbGpPWpGaD
Flupentixol—HTR2A—Signaling Pathways—KNG1—peripheral nervous system neoplasm	2.85e-05	0.000371	CbGpPWpGaD
Flupentixol—CHRM1—Signaling Pathways—KNG1—peripheral nervous system neoplasm	2.83e-05	0.000369	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling Pathways—KNG1—peripheral nervous system neoplasm	2.79e-05	0.000363	CbGpPWpGaD
Flupentixol—DRD2—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	2.76e-05	0.000359	CbGpPWpGaD
Flupentixol—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—peripheral nervous system neoplasm	2.72e-05	0.000354	CbGpPWpGaD
Flupentixol—HTR2A—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	2.71e-05	0.000353	CbGpPWpGaD
Flupentixol—CHRM1—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	2.7e-05	0.000352	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	2.66e-05	0.000346	CbGpPWpGaD
Flupentixol—DRD2—Signaling Pathways—GNAS—peripheral nervous system neoplasm	2.53e-05	0.00033	CbGpPWpGaD
Flupentixol—HTR2A—Signaling Pathways—GNAS—peripheral nervous system neoplasm	2.49e-05	0.000324	CbGpPWpGaD
Flupentixol—CHRM1—Signaling Pathways—GNAS—peripheral nervous system neoplasm	2.48e-05	0.000323	CbGpPWpGaD
Flupentixol—ABCB1—Metabolism—BCHE—peripheral nervous system neoplasm	2.44e-05	0.000318	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling Pathways—GNAS—peripheral nervous system neoplasm	2.44e-05	0.000318	CbGpPWpGaD
Flupentixol—DRD1—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	2.37e-05	0.000309	CbGpPWpGaD
Flupentixol—DRD1—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	2.33e-05	0.000303	CbGpPWpGaD
Flupentixol—ABCB1—Metabolism—SLC2A1—peripheral nervous system neoplasm	2.33e-05	0.000303	CbGpPWpGaD
Flupentixol—ABCB1—Metabolism—TH—peripheral nervous system neoplasm	2.29e-05	0.000299	CbGpPWpGaD
Flupentixol—DDC—Metabolism—AKT1—peripheral nervous system neoplasm	2.07e-05	0.00027	CbGpPWpGaD
Flupentixol—ABCB1—Metabolism—GNAS—peripheral nervous system neoplasm	1.87e-05	0.000244	CbGpPWpGaD
Flupentixol—DRD1—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	1.84e-05	0.00024	CbGpPWpGaD
Flupentixol—DRD2—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	1.79e-05	0.000233	CbGpPWpGaD
Flupentixol—HTR2A—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	1.76e-05	0.000229	CbGpPWpGaD
Flupentixol—DRD2—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	1.76e-05	0.000229	CbGpPWpGaD
Flupentixol—CHRM1—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	1.75e-05	0.000228	CbGpPWpGaD
Flupentixol—DRD1—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	1.73e-05	0.000226	CbGpPWpGaD
Flupentixol—HTR2A—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	1.73e-05	0.000225	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	1.72e-05	0.000225	CbGpPWpGaD
Flupentixol—CHRM1—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	1.72e-05	0.000224	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	1.69e-05	0.000221	CbGpPWpGaD
Flupentixol—DRD1—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	1.69e-05	0.00022	CbGpPWpGaD
Flupentixol—DRD1—Signaling Pathways—CASP3—peripheral nervous system neoplasm	1.67e-05	0.000218	CbGpPWpGaD
Flupentixol—DRD1—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	1.53e-05	0.000199	CbGpPWpGaD
Flupentixol—DRD1—Signaling Pathways—NRAS—peripheral nervous system neoplasm	1.4e-05	0.000182	CbGpPWpGaD
Flupentixol—DRD2—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	1.39e-05	0.000181	CbGpPWpGaD
Flupentixol—HTR2A—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	1.37e-05	0.000178	CbGpPWpGaD
Flupentixol—CHRM1—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	1.36e-05	0.000177	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	1.34e-05	0.000174	CbGpPWpGaD
Flupentixol—DRD2—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	1.31e-05	0.000171	CbGpPWpGaD
Flupentixol—DRD1—Signaling Pathways—MYC—peripheral nervous system neoplasm	1.3e-05	0.00017	CbGpPWpGaD
Flupentixol—HTR2A—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	1.29e-05	0.000168	CbGpPWpGaD
Flupentixol—CHRM1—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	1.28e-05	0.000167	CbGpPWpGaD
Flupentixol—DRD2—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	1.27e-05	0.000166	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	1.26e-05	0.000164	CbGpPWpGaD
Flupentixol—DRD2—Signaling Pathways—CASP3—peripheral nervous system neoplasm	1.26e-05	0.000164	CbGpPWpGaD
Flupentixol—HTR2A—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	1.25e-05	0.000163	CbGpPWpGaD
Flupentixol—CHRM1—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	1.25e-05	0.000162	CbGpPWpGaD
Flupentixol—HTR2A—Signaling Pathways—CASP3—peripheral nervous system neoplasm	1.24e-05	0.000162	CbGpPWpGaD
Flupentixol—CHRM1—Signaling Pathways—CASP3—peripheral nervous system neoplasm	1.23e-05	0.000161	CbGpPWpGaD
Flupentixol—ADRA1A—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	1.23e-05	0.00016	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling Pathways—CASP3—peripheral nervous system neoplasm	1.22e-05	0.000158	CbGpPWpGaD
Flupentixol—DRD2—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	1.16e-05	0.000151	CbGpPWpGaD
Flupentixol—HTR2A—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	1.14e-05	0.000148	CbGpPWpGaD
Flupentixol—CHRM1—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	1.13e-05	0.000147	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	1.11e-05	0.000145	CbGpPWpGaD
Flupentixol—DRD1—Signaling Pathways—TP53—peripheral nervous system neoplasm	1.07e-05	0.00014	CbGpPWpGaD
Flupentixol—DRD2—Signaling Pathways—NRAS—peripheral nervous system neoplasm	1.06e-05	0.000138	CbGpPWpGaD
Flupentixol—HTR2A—Signaling Pathways—NRAS—peripheral nervous system neoplasm	1.04e-05	0.000136	CbGpPWpGaD
Flupentixol—CHRM1—Signaling Pathways—NRAS—peripheral nervous system neoplasm	1.03e-05	0.000135	CbGpPWpGaD
Flupentixol—DRD1—Signaling Pathways—HRAS—peripheral nervous system neoplasm	1.02e-05	0.000133	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling Pathways—NRAS—peripheral nervous system neoplasm	1.02e-05	0.000133	CbGpPWpGaD
Flupentixol—DRD2—Signaling Pathways—MYC—peripheral nervous system neoplasm	9.85e-06	0.000128	CbGpPWpGaD
Flupentixol—HTR2A—Signaling Pathways—MYC—peripheral nervous system neoplasm	9.69e-06	0.000126	CbGpPWpGaD
Flupentixol—CHRM1—Signaling Pathways—MYC—peripheral nervous system neoplasm	9.64e-06	0.000126	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling Pathways—MYC—peripheral nervous system neoplasm	9.49e-06	0.000124	CbGpPWpGaD
Flupentixol—DRD1—Signaling Pathways—AKT1—peripheral nervous system neoplasm	9.04e-06	0.000118	CbGpPWpGaD
Flupentixol—DRD2—Signaling Pathways—TP53—peripheral nervous system neoplasm	8.09e-06	0.000105	CbGpPWpGaD
Flupentixol—HTR2A—Signaling Pathways—TP53—peripheral nervous system neoplasm	7.96e-06	0.000104	CbGpPWpGaD
Flupentixol—CHRM1—Signaling Pathways—TP53—peripheral nervous system neoplasm	7.91e-06	0.000103	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling Pathways—TP53—peripheral nervous system neoplasm	7.79e-06	0.000102	CbGpPWpGaD
Flupentixol—DRD2—Signaling Pathways—HRAS—peripheral nervous system neoplasm	7.73e-06	0.000101	CbGpPWpGaD
Flupentixol—HTR2A—Signaling Pathways—HRAS—peripheral nervous system neoplasm	7.61e-06	9.91e-05	CbGpPWpGaD
Flupentixol—CHRM1—Signaling Pathways—HRAS—peripheral nervous system neoplasm	7.57e-06	9.86e-05	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling Pathways—HRAS—peripheral nervous system neoplasm	7.45e-06	9.71e-05	CbGpPWpGaD
Flupentixol—DRD2—Signaling Pathways—AKT1—peripheral nervous system neoplasm	6.83e-06	8.9e-05	CbGpPWpGaD
Flupentixol—HTR2A—Signaling Pathways—AKT1—peripheral nervous system neoplasm	6.72e-06	8.75e-05	CbGpPWpGaD
Flupentixol—CHRM1—Signaling Pathways—AKT1—peripheral nervous system neoplasm	6.68e-06	8.71e-05	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling Pathways—AKT1—peripheral nervous system neoplasm	6.58e-06	8.57e-05	CbGpPWpGaD
Flupentixol—ABCB1—Metabolism—AKT1—peripheral nervous system neoplasm	5.06e-06	6.59e-05	CbGpPWpGaD
